Evidence map›Paper›PMID 39870504›Full record

ArticleLife science alliance2025

A role for mitochondria-ER crosstalk in amyotrophic lateral sclerosis 8 pathogenesis.

Cathal Wilson, Laura Giaquinto, Michele Santoro, Giuseppe Di Tullio, Valentina Morra, Wanda Kukulski, Rossella Venditti, Francesca Navone, Nica Borgese, Maria Antonietta De Matteis

Abstract read
In one paragraph

Article in Life science alliance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Cathal WilsonTelethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Italy cathalwilson636@gmail.com.
Laura GiaquintoTelethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Italy.ORCID 0000-0003-0678-4339
Michele SantoroTelethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Italy.
Giuseppe Di TullioTelethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Italy.
Valentina MorraTelethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Italy.
Wanda KukulskiInstitute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
Rossella VendittiTelethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Italy.ORCID 0000-0002-1884-6501
Francesca NavoneCNR Neuroscience Institute, Vedano al Lambro, Italy.
Nica BorgeseCNR Neuroscience Institute, Vedano al Lambro, Italy.ORCID 0000-0002-7537-3974
Maria Antonietta De MatteisTelethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Italy dematteis@tigem.it.ORCID 0000-0003-0053-3061

Funding

Medical Research Council / United Kingdom Research and Innovation MC_UP_1201/8
6 · The paper itself

Abstract

Protein aggregates in motoneurons, a pathological hallmark of amyotrophic lateral sclerosis, have been suggested to play a key pathogenetic role. ALS8, characterized by ER-associated inclusions, is caused by a heterozygous mutation in VAPB, which acts at multiple membrane contact sites between the ER and almost all other organelles. The link between protein aggregation and cellular dysfunction is unclear. A yeast model, expressing human mutant and WT-VAPB under the control of the orthologous yeast promoter in haploid and diploid cells, was developed to mimic the disease situation. Inclusion formation was found to be a developmentally regulated process linked to mitochondrial damage that could be attenuated by reducing ER-mitochondrial contacts. The co-expression of the WT protein retarded P56S-VAPB inclusion formation. Importantly, we validated these results in mammalian motoneuron cells. Our findings indicate that (age-related) damage to mitochondria influences the propensity of the mutant VAPB to form aggregates via ER-mitochondrial contacts, initiating a series of events leading to disease progression.

Indexed as

Amyotrophic Lateral SclerosisEndoplasmic ReticulumMitochondriaAnimalsHumansMotor NeuronsMutationProtein Aggregation, PathologicalSaccharomyces cerevisiaeVesicular Transport ProteinsVAPB protein, humanVesicular Transport Proteins

Identifiers

PMID39870504
PMCPMC11772500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.